Full Course Description

The Hero’s Journey in Medicine & Beyond

Dr. Damania will discuss the transition to Health 3.0 through the monomyth of the Hero’s Journey. He will pay special attention to burnout and moral injury in the healthcare workforce and discuss how we can forge a new way for delivering care that is compassionate, relationship-based and technology-enabled. Dr. Damania will provide guidance and inspiration to dispel your doubts and fears, while also giving you strength and courage to begin the quest!

Program Information

Objectives

Identify the elements of the classic hero’s journey in individuals and our healthcare system.
Determine the root causes of provider burnout, moral injury and suffering.
Identify approaches to self-realization that address the root causes of suffering.
Explain new financial and care models that aim to deliver cost-effective, high-quality care while integrating left brain and right brain approaches.

Outline

The Hero’s Journey

Why it is relevant individually and systemically
Introduce the process of awakening and self-realization

Left Brain vs. Right Brain

Discuss the different approaches of the two hemispheres

Health 1.0

Review the old system as a starting place for the hero’s journey, pure right brain medicine

Health 2.0

Review the current medical paradigm, pure left brain medicine
The Hero’s Journey into trials and tribulations
Role of The Mentor

The Roots of Moral Injury/Burnout

Review of the current challenges in our healthcare system related to fee-for-service incentives
Malpractice considerations
Increasing administrative burden
Inability to focus on or get reimbursed for preventative and holistic approaches
Discuss mind-identification and thought-belief

The Hero’s Journey

The role of creative destruction of the false self and awakening
The role of meditation, retreats, practices

Health 3.0

Integration of left and right brain approaches with appropriate dominance of right hemisphere holistic approach
Discussion of medical models of Health 3.0

Awakening/Meditation

Sample techniques such as self-inquiry, natural meditation, and others

Copyright : 04/20/2023

Opioid Prescribing Strategies: Based on New CDC Guidelines

Opioid medications are very powerful pain killers which are extremely addictive. According to the Centers for Disease Control and Prevention, more than 100,000 people died of drug overdoses in the United States during the 12-month period May 2020 to April 2021, reflecting a new record high.

According to the 2020 National Survey on Drug Use and Health (NSDUH), sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA) among people aged 12 and older in 2020, 1% (or 2.7 million people) had an opioid use disorder in the past year.

Prescription opioids have been suggested to be an important gateway drug. In fact, opioids should not be the first-line treatment for chronic pain. Health care providers should first consider nonopioid pain relievers or nonpharmacological options.

To mitigate this explosion of opioid-associated morbidity and mortality, Dr. Paul Langois will discuss methods to mitigate the opioid crisis thru judicious prescribing, proper tapering and through a thorough patient follow-up. Numerous case studies will be used throughout this presentation to solidify the learning experience. Dr. Langlois has lectured on this topic to several multidisciplinary healthcare audiences in recent years.

Program Information

Objectives

Describe three non-opioid interventions to manage acute pain.
Discriminate between natural, synthetic and semi-synthetic opioids in management of pain.
State one method used to taper opioid medications.
Describe two methods to identify opioid abuse.

Outline

Opioid use and abuse

Mortality and morbidity
Epidemiology

Treating pain without opioids

Noninvasive nonpharmacologic approaches to pain management
Nonopioids for pain control
Acute pain
- Neuropathic pain
- Non-neuropathic pain
Case studies

Selecting opioids for pain management and dose ranges

Types of opioids and dosages
- Natural
- Synthetic
- Semi-synthetic
Immediate release versus extended release
Tapering opioids: When and how
Duration of opioids for pain
Initial follow-up appointment
Case studies

Pathophysiology of opioid use and abuse

Assessing potential opioid harm and risk

Pregnant women
Elderly
Renal or hepatic insufficiency
Case studies

Differential diagnosis of opioid abuse disorder

Treatment

Opioid overdose
Opioid intoxication
Maintenance therapy
Preventing relapse
Pain management

Substance Abuse and Mental Health Services Administration (SAMHSA) Guidelines

Copyright : 04/20/2023

Simple and Complex UTI Management: With E. coli Resistance Considerations

This session will dissect the evolving landscape for managing the spectrum of urinary tract infections in light of the increasing prevalence of E. coli resistance. Time will be spent exploring trends in E. coli resistance and the associated impact on antimicrobial selection particularly for complicated urinary tract infections, including pyelonephritis. The session will review recommendations for managing non-typical urinary pathogens, such as Candida. Attention will be given to non-antibiotic approaches to limit recurrent urinary tract infections, and guidance for managing asymptomatic bacteriuria.

Program Information

Objectives

Describe resistance trends of urinary pathogens in the community.
Formulate effective evidence-based treatment regimens for simple cystitis.
Integrate cephalosporins for successful management of complicated urinary tract infections.
Contact antibiotic and non-antibiotic approaches to prevent recurrent urinary tract infections.
Distinguish clinical scenarios requiring initiation of antimicrobials in response to bacteriuria.

Outline

Resistance

Evidence of changing resistance patterns to typical urinary antimicrobials for common urinary pathogens

Simple Cystitis

Nitrofurantoin evidence and pharmacology
Fosfomycin evidence and pharmacology

Complicated Cystitis

Etiological considerations/resistance in complicated cystitis
Cephalosporins
Fosfomycin

Pyelonephritis

Evaluate evidence for cephalosporin use in pyelonephritis
Drug overdosing and kinetics considerations

Atypical Urinary Pathogens

Approach to Candida
Approach to other pathogens

Recurrent UTI

Antibiotic prophylaxis
Methenamine prophylaxis
topical estrogen prophylaxis

Asymptomatic Bacteriuria

Definitions and Guideline Recommendations
Impact of antibiotic use

Copyright : 04/20/2023

Parkinson’s Disease: Current Pharmacologic Methods of Treatment

Parkinson disease is a heterogeneous disease with rapidly and slowly progressive forms. Treatment involves pharmacologic approaches (typically with levodopa preparations prescribed with or without other medications) and nonpharmacologic approaches (such as exercise and physical, occupational, and speech therapies). Our emphasis in this training session will be on current evidence to guide medication selection. Approaches such as deep brain stimulation and treatment with levodopa-carbidopa enteral suspension can help individuals with medication-resistance tremor, worsening symptoms when the medication wears off, and dyskinesias.

Program Information

Objectives

Develop a predication model for diagnosis of Parkinson’s Disease based on presentations in primary care.
Describe the current treatment options of Parkinson’s Disease.
Analyze nonpharmacologic and pharmacologic methods of treatment of Parkinson’s.
Evaluate deep brain stimulation and treatment with levodopa-carbidopa enteral suspension to help individuals with medication-resistant tremor, worsening symptoms when the medication wears off, and dyskinesias.

Outline

Clinical Significance

Defined primarily by motor symptoms including tremor, bradykinesia and akinesia
May demonstrate non-motor symptoms such as cognitive decline, depression, anxiety, sleep disturbance and dysautonomia
Dopaminergic medications and deep brain stimulation for motor symptom treatment

Clinical Presentation to Guide Pharmacological Decisions

Assessment
Imaging
Co-morbidities

Evidence Based Treatments

Medications
Nonpharmacy
Surgeries
Rehab

Copyright : 04/20/2023

Adult ADHD Medications & The Recent Increase in Prevalence

There has been a lot of buzz about Attention-Deficit/Hyperactivity Disorder (ADHD) in the media lately. The number of adults seeking ADHD diagnosis and treatment has rapidly increased in the past 3 years and as a result, we now have a shortage of Adderall. However, it remains to be estimated that 80% of adults with ADHD are UNDIAGNOSED.

In this session for the Modern Clinician, you’ll understand:

Implicit Bias – are you harboring negative feelings about diagnosing and treating Adult ADHD, or whether Adult ADHD is real?
Neurobiology of ADHD – a brief and digestible, yet thorough update on our current understanding of pathophysiology of ADHD
Safely treating attention deficit symptoms with stimulants and non-stimulants
Medication Management: how to choose, start, taper, and monitor effectiveness

Program Information

Objectives

Analyze the prevalence, pathophysiology, and manifestations of Adult ADHD.
Anticipate the deficits in, and impacts of, Adult ADHD.
Acknowledge any implicit bias and develop a position of compassion and empathy.
Express confidence that you can diagnose and manage Adult ADHD.

Outline

Neuroanatomy and pathophysiology

The cortex, limbic system, and brain stem structures and functions
Genetics of ADHD and brain structures involved
Dopamine pathway
Norepinephrine pathway
Brain wave patterns – regulating alertness

Executive Function (EF)

Disorder of doing what you know
Elements of EF
Evolution of and innate development of EF
Deficits result in Impairments = Executive Dysfunction
Executive Dysfunction is situationally dependent
heterogeneity of impairments/symptoms

Assessment

DSM-V
A clinicians’ duty
Diagnosis rates, average ages and impacts of late diagnosis
Differential diagnosis and Diagnostic process
- Rating scales
- Getting input from collaterals
- tips for differentiating diagnosis

Treatment

Guiding principles of treatment
Stimulants deep dive
- Amphetamine
- Methylphenidate
Non-stimulants deep dive
- Alpha agonists
- Norepinephrine reuptake inhibitors
- Off-label medications
Benefits are addictive, combinations limited by side effects
- A handy prescribing reference chart to use in practice
Micronutrients
Lifestyle and therapeutic interventions
- Guiding principles and evidence-based recommendations
Comorbidities
- MDD and treatment options
- GAD and treatment options
- ASD and treatment options

Copyright : 04/21/2023

Inflammatory Bowel Disease: Combination of New & Traditional Treatments

The evaluation and treatment of Inflammatory Bowel Disease (IBD) has dramatically changed in the last several years. These changes have improved the quality of life for many patients. In this session, Dr. Peter Buch will be discussing the new and traditional therapies. He will highlight the pros and cons of each category. He will discuss how to select the “best” therapy for your patient. He will also be identifying when surgery is the best option. This session is a case-based, practical, very interactive and fun format geared toward those who have some experience in treating IBD patients.

Program Information

Objectives

Distinguish Inflammatory Bowell Disease from Irritable Bowel Syndrome.
Analyze the workup for Inflammatory Bowell Disease.
Recognize the treatment categories for Inflammatory Bowel Disease.
Discriminate the controversies surrounding Inflammatory Bowell Disease.

Outline

How to distinguish Inflammatory Bowel Disease (IBD) form Irritable Bowel Syndrome (IBS)

Usefulness of “Alarm Signs”
How to distinguish Chron’s Disease from Ulcerative Colitis
Which one curable, which one treatable?
Smoking
Evaluation/prognosis
Extra intestinal manifestations
Goals of treatment

Medication Categories

5 ASAs
Antibiotic use in Chron’s Disease
Steroids
- Dose
- Risks
- Duration
- Tricks of taper
Thiopurines
- Risks/benefits
- Monotherapy?
  - How to use TMTP testing
- Monitoring for side effects
Methotrexate
Anti TNFs
- Risks/benefits
- Limitations
- Comparing products
Vedolizumab
- Indications/risks/benefits
Ustekinumab
- Indications/risks/benefits
Tofacininub
- Indications/risks/benefits
Ozanimod
- Indications/risks/benefits
Upadacitinib
- Indications/risks/benefits
- Risankizumab-raa
  - Indications/risks/benefits
- Biosimlars
  - What we know so far

Unanswered questions in IBD

What is the “best” medicine for my patient
Genomics? And other markers
Head to head studies mostly lacking
Who should receive combination therapy?
- Risks/benefits
Should medications ever be stopped if pt doing well?

How successful is medical treatment?

Surgical alternatives

Copyright : 04/21/2023

Dementia Medication Update

Dementia of any type is a chronic disease with progressive deterioration of cognition, function, and behavior. The prevalence is only expected to increase as the patient population ages. This will result in a considerable challenge to patients, families, caregivers and facilities. Knowing the pharmacological DO’s and DON’TS for those with dementia can change outcomes, but understanding what not to prescribe can be difficult. In this session, hear a Geriatrician’s approach to the newest diagnostics and treatments in dementia, screening for the pharmacological deliriants that contribute to dementia, and placing emphasis on deprescribing unnecessary medications.

Program Information

Objectives

Evaluate drug choices based on dementia type.
Determine tools to help in diagnosing common dementia types.
Analyze common pharmacological deliriants.
Determine the value of deprescribing in dementia care.

Outline

Delirium

The current algorithm of delirium
A simpler approach to delirium

The Importance of Screening for Depression

How Medications Can Confound the Picture

The Anticholinergic Burden Score

The Importance of Cognitive Screens

A screening test for all settings

Alzheimer’s Disease

The general hypothesis
The value of screening
The NEWEST biological definition of SDAT
LATE-NC – newly defined form of dementia

Copyright : 04/21/2023

Diabetes Medications: The Latest Treatments & Guidelines

Advancements in research and treatment for diabetes mellitus is exciting. With 9 classes of diabetes medications now available, there are a lot of options, but it can also be confusing to choose which medications are best to treat your patient with diabetes. Devising an individualized plan of care for each patient requires that your practice is up-to-date and based on the current evidence-based guidelines. Tracey Long, PhD, MSN, MS, RN, APRN-BC, CDE, CNE, CCRN, will share her expertise on the pharmacological management in this evolving specialty.

Program Information

Objectives

Differentiate between the nine currently available classes of medications to treat diabetes.
Apply ADA and AACE practice guidelines for medication decision making.
Describe side effects and effectiveness used for treatment of diabetes mellitus.
Explain the use of combination therapy for treatment of chronic hyperglycemia.

Outline

Diabetes Medication Classes

Oral antihyperglycemics: alpha-glucosidase inhibitors, biguanides, DPP4-inhibitors, meglitinides, SGLT2 inhibitors, sulfonylureas, thiazolidinediones
Injectable antihyperglycemics (not insulin): amylin analogs, incretin mimetics, GLP-1 agonists
Insulins: rapid, regular, intermittent, long acting

ADA and AACE Practice Guidelines

What has changed for 2022
Standards of care and diagnosing
Glycemic control algorithm
Guidelines for monotherapy and combination therapy

Comparison of Medication Side Effects

Medication decisions include side effects, organ effect, and adverse drug effects

Up-to-Date Prescription of Insulin

Insulin delivery systems: syringe, pen, pump, and inhaled insulin
Algorithm for adding/intensifying insulin
Patient education for storage, mixing and traveling
Multiple daily injections vs. continuous glucose monitoring

Target Audience

Nurses
Nurse Practitioners
Physicians
Physicians Assistants

Copyright : 03/25/2022

Complex Geropharmacy: Atypical Symptoms, Comorbidities & New Standards

Geropharmacy is both an art and a science. The confusion can lie between knowing when and how to separate the two. 

As you evaluate medication usage in the elderly, especially in terms of fall risk or cognitive impairment, a well-planned decision-making process makes a dramatic impact on outcomes.

Learn how the current body of science can demonstrate statistically significant benefits. That vital information is then coupled with the art of knowing your geriatric patients goals to prescribe/deprescribe on an individualized basis.  

Program Information

Objectives

Appraise the risk factors for an adverse drug reaction.
Apply five key principles to deprescribe medications.
Distinguish between appropriate and inappropriate medication management of Alzheimer’s disease.
Develop best practice methods to avoid medications that contribute to Alzheimer's disease.
Evaluate the types of medications that statistically increase fall risk.
Plan your response once a medication has been identified that could be contributing to a patient’s falls.

Outline

Geropharmacy

Adverse drug reactions
5 principles to describe medications
Medication adherence
Impact from complementary and alternative medications

Fall Risk, Cognition & Medication Use

Cardiovascular medications
Neurological medications
Medications to treat peripheral disorders
Psychotropic medications
Treatments for insomnia
Urinary incontinence treatments
American Geriatrics Society recommendations
Joint decision making with patient

Target Audience

Nurses
Nurse Practitioners
Physicians
Physicians Assistants

Copyright : 02/04/2022

Prescribing Heart Failure Medications: The Latest Updates for Life-Saving Clinical Decisions

Heart Failure is a complex clinical syndrome. The heart failure diagnosis alone can scare even the most adept and proficient providers.  It is not uncommon to feel as though we don’t want to change the medications for fear of causing harm.

Years of research and collaboration amongst the most respected experts in the heart failure field have proven that neurohormonal dysregulation is what causes the decline of patients with heart failure. When it comes to the medicinal management of heart failure, utilizing guideline directed medical therapy appropriately is misunderstood. It is not merely a pump problem but rather a brain and pump problem. The indications, patient education, up-titration, vital sign parameters, and adjuvant therapies are very specific to the pathology of the failing heart.

Program Information

Objectives

Analyze neurohormonal dysregulation as the primary trigger for worsening heart failure.
Differentiate the indications for GDMT in heart failure vs. other cardiovascular comorbidities. 
Determine how to concomitantly use available resources to optimize heart failure management.
Plan how to prescribe and up-titrate heart failure medications based on clinical criteria.
Appraise the effectiveness of prescribed therapies.

Outline

Neurohormonal Dysregulation

What is really causing the failure
RAAS 
Shutting it down

Guideline Directed Medical Therapy (GDMT)

The VIM’s:  Beta adrenergic blockers
The VIM’s:  ACEi/ ARB’s
The VIM’s:  Where’s ALDO?
The VIM’s:  The new player:  ARNI
The VIM’s: SGLT2 inhibition

What do they each do?

Critical importance of appropriate integration
Tips and tricks for patient tolerance
Monitoring

The VIM’s:  Stay in the Loop with Diuretics

Do HF patients ALWAYs need diuretics?
Subclasses of diuretics to consider
Thiazides and thiazide-like diuretics
Carbonic anhydrase inhibitors
Potassium-sparing diuretics
Osmotic diuretics

Non-Pharmacologic Interventions for Heart Failure Management

Electrophysiology involvement
- ICD’s
- Pacemakers
- BiV-ICD
PA pressure system
- Using monitoring to up-titrate GDMT
Social media as patient support
Support groups for patients with heart failure

Treatment Options 

Referral to HF specialist
Treating the cause
LVAD
Cardiac transplantation

Target Audience

Nurses
Nurse Practitioners
Pharmacists
Physicians
Physician Assistants

Copyright : 05/20/2022

Weight Loss Medications: Evaluate Evidence, Risk & Cost for Prescriptive Decisions

You’ve seen it too….

With the goal of losing weight, patients will try endless efforts and gimmicks. As providers, we have explained the importance of maintaining a healthy weight and lifestyle. These conversations can lead to frustrations, for everyone involved.

Studies show a 5-7% weight loss with behavior changes (a mere 10-15 pounds for a 200-pound person). Often weight loss efforts lead to weight cycling, which carries documented health risks and often leads to higher than initial weights. In the past there have been a lot of assumptions about the cause of weight being more behavioral. Newer evidence supports a more genetic, environmental, and biologic relationship with weight.

However, many healthcare providers continue to recommend behavior changes for weight loss, despite documented research showing not only poor success with those tactics but great harm including weight stigma, decreased utilization or delay in medical care, repeated weight loss and regain/weight cycling, reduced self-esteem/motivation, eating disorders, stress, and depression. All of which have been shown to contribute negatively to overall health.

The seriousness of this situation has led both patients and providers to look at pharmacological interventions to manage weight. These options have significant cost and risk that need to be carefully considered against the potential benefits. You have an incredible opportunity to learn from Laurie Klipfel, RN, MSN, ANP-BC, CDCES, WCC, as she breaks down the very latest evidence supported weight loss medication options.

Imagine being able to support the lasting weight loss outcomes you’ve been hoping patients would experience! Purchase today!

Program Information

Objectives

Apply the latest evidence to select current pharmacological options for weight loss in patients.
Analyze the benefit vs cost and risk of the various weight loss medication options available today.
Evaluate the effect on weight for medications intended to treat other ailments such as hypertension, diabetes, or depression.
Determine benefits of focusing on outcomes such as health/longevity, rather than weight.
Choose therapies that best meet individual needs and provide effective support.
Investigate how big business can influence standards/recommendations for healthcare providers regarding weight loss options.
Develop techniques for successful motivational interviewing.

Outline

Current Non-Pharmacological Options

“Healthy” Diets

Dash diet
Mediterranean diet
Paleo
Atkins
Keto
Plant-based diet
Commercially prepared meals
Commercial weight loss plans

Activity

Cardio/aerobic
Resistance training/anerobic
Stretch/flexibility
Precautions

Stress management
Sleep hygiene
Surgical options
Motivational techniques to maintain healthy habits and avoiding fads

Pharmacological Options for Weight Loss

Older Medications Taken Off the Market Due to Complications

Sibutramine
Fenfluramine/phentermine “fen-phen”
Lorcaserin
Limitations/bias of older recommendations

FDA Approved Medications for Weight Loss (Effectiveness, Dosage, Side Effects, Warnings, Cost)

Orlistat
Phentermine/topiramate
Naltrexone/buproprion
Liraglultide
Semaglutide
Setmelanotide (only approved for 3 rare genetic conditions)

Medications Approved for Short Term Use Only (12 weeks)

Phentermine
Benzphetamine
Diethylpropion
Phendimetrazine

Medications Used Off Label for Weight Loss

A drug approved for treating a different medical problem
Two or more drugs at the same time
A drug for a longer time period than approved by the FDA

“Food Supplements” Not Under FDA Guidelines

Potential Mechanisms of Action for Future Medications

Regulating several gut hormones at the same time
Targeting specific genes that cause obesity
Allowing people to lose body fat without losing muscle during weight loss
Changing bacteria in the gut to control weight

Medications Used for Other Conditions that Affect Weight

Diabetes medications
Hypertension medications
Psychiatric medications

Target Audience

Nurse Practitioners
Clinical Nurse Specialists
Nurses
Physician Assistants
Pharmacists
Dietitians
Certified Diabetes Care and Education Specialists

Antiseizure Medications: Prescribing for Effectiveness

Join Filissa M Caserta MSN, ACNP-BC, CNRN, for an important antiseizure medication update. The purpose of this class is to increase your competence to: manage patients that have a known seizure disorder who are on antiseizure medications, identify patients at risk for seizures and understand the impact of concurrent conditions (co-morbidities) on seizure frequency and antiseizure medication effectiveness.

Program Information

Objectives

Evaluate the pharmacology of the most common antiseizure medications.
Choose the most appropriate first line antiseizure medication for focal onset seizures.
Plan for the most common side effects of antiseizure medications.
Determine which antiseizure medications require therapeutic monitoring.
Assess the impact of pregnancy on seizure frequency.

Outline

Antiseizure Medications

Classification
Pharmacology
Side effects
Interactions
Toxicities

Recommended Medications by Seizure Type

Focal onset
Generalized

Special Considerations

Therapeutic monitoring
Alcohol consumption
Non-adherence
Geriatric patients
Women (contraception and pregnancy)
Driving

Target Audience

Nurses
Nurse Practitioners
Physicians
Physicians Assistants

Updates for Treating Depression: Link the Mechanism of Action to the Clinical Target

You see it in your practice setting, too. Depressive disorders are affecting patients, often in very significant ways. With almost 60% of mental health care delivery taking place in the primary care setting and most antidepressant prescriptions being written by providers who are not mental health providers, it is essential you are up-to-date to optimally recognize and manage depression.

JeanAnne Johnson Talbert, DHA, APRN-BC, FNP, PMHNP, an expert in the pharmacological treatment of mental illnesses will examine strategies to combat treatment resistant depression, share how you can link the mechanism of action to the clinical target for patient outcomes and highlight new medication options available.

Program Information

Objectives

Analyze the neurochemical basis of unipolar depression.
Determine the mechanism of action, indications, and adverse effects of therapeutic agents used to treat unipolar depression.
Plan for treatment of unipolar depression by linking the mechanisms of action to the clinical targets to optimize response.
Choose prescriptive options for treatment resistant depression, including augmentation and switching antidepressants.
Differentiate between novel and evolving antidepressant agents.

Outline

Diagnostic Criteria

Unipolar depression
Differentiating from bipolar depression

Neurochemical Changes that Occur in Depression

Selection of antidepressants based upon how they work in the brain
Updates on the different classes of antidepressants: SSRIs, SNRIs, TCA, MAOI, others

Prescribing Best Practices

Tips on prescribing, dosing, titrating, and discontinuing
How to best augment or make a change to the antidepressant treatment plan
Next steps when the current medication is not providing remission

New Agents for the Treatment of Unipolar Depression

Mechanism of action
How they are used
Potential adverse effects

Target Audience

Nurses
Nurse Practitioners
Pharmacists
Physicians
Physician Assistants

Pharmacology of Herbal Therapeutics

Herbal supplements and nutraceuticals are increasingly used by patients to treat common conditions and symptoms. Vanessa Ruiz, ND, RN-BSN, will share from her expertise on their common uses, mechanism of actions, medication interactions, side effects and pharmacokinetic drug-herb interactions. She will discuss supplement product quality and effectiveness in clinical practice. Commonly used supplements such as Black Cohosh, Gingko, Valerian and more will be discussed. After completing this training, you will gain knowledge of integrative treatment in practice and how to incorporate safely in herbs in your treatment plans.

Program Information

Objectives

Analyze commonly used medicinal herbs.
Assess potential drug-to-herb interactions.
Evaluate pharmacological actions and therapeutics of commonly used herbal medicines.
Determine appropriate use and indications for herbal medicines and supplementation in the practice.
Formulate an integrative plan for common patient care ailments.

Outline

Quality, Safety of Supplementation and Herbs 
Cardiovascular Support 
Anti-inflammatory Herbs and Pain Management
Gastrointestinal Support 
Endocrine Support 
Pulmonary Support 
Immune System Focused Herbs 
Common Herbs for Brain Health and Mood

Target Audience

Nurses
Nurse Practitioners
Physicians
Physicians Assistants